D.Bilim Avesis
D.Bilim Avesis
TR
EN
Yayınlar & Eserler
SCI, SSCI ve AHCI İndekslerine Giren Dergilerde Yayınlanan Makaleler 51
Original vs. Generic Plerixafor for the Mobilization of Stem Cells in Multiple Myeloma Patients
Obinutuzumab interference with immunoelectrophoresis in a case of follicular lymphoma
Single agent vemurafenib or rituximab-vemurafenib combination for the treatment of relapsed/refractory hairy cell leukemia, a multicenter experience
Eltrombopag treatment in thrombocytopenia following hematopoietic stem cell transplantation: A multicenter real-world experience
Germline genetic variants in Turkish familial multiple myeloma/monoclonal gammopathy of undetermined significance cases
Successful use of split-dose intravenous daratumumab in a multiple myeloma patient after a first-dose life-threatening infusion-related reaction
Plerixafor in autologous stem cell transplantation: Does it affect engraftment kinetics?
Glofitamab in relapsed/refractory diffuse large B-cell lymphoma: Real-world data
Birtaş Ateşoğlu E.
Gülbaş Z.
Uzay A.
Özcan M.
Özkalemkaş F.
Dal M. S.
Kalyon H.
Akay O. M.
Deveci B.
Bekoz H.
Sevindik Ö. G.
Toptaş T.
Yilmaz F.
Koyun D.
Alkış N.
Alacacıoğlu İ.
Sönmez M.
Yavaşoğlu İ.
Tombak A.
Mehtap Ö.
Kurnaz F.
Yuce O. K.
Karakuş V.
Turgut M.
Deniz Kürekçi D.
Ayer M.
Keklik M.
Büyüktaş D.
Ozbalak M.
Ferhanoglu B.
Daha Fazlası
Intravascular B-cell lymphoma with generalized telangiectasias
Inherited transmission of the CSF3R T618I mutation: a familial report
The effect of haemoglobin, albumin, lymphocyte and platelet score on the prognosis in patients with multiple myeloma
Gilteritinib (XOSPATA®) in Turkey: Early Access Program Results
First-line Usage of Daratumumab, Lenalidomide, Dexamethasone (DRd) Combination in a Case of Castleman Disease Variant of Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Gammopathy, and Skin Changes Syndrome (CD-POEMS)
Tocilizumab treatment in severe COVID-19: a multicenter retrospective study with matched controls
Mert A.
Vahaboğlu H.
Arslan F.
Batırel A.
Saraçoğlu K. T.
Baştuğ A.
Çağatay A.
Irmak İ.
Telli Dizman G.
Ertenli İ.
Altunal L. N.
Ertürk Şengel B.
Bayram M.
Omma A.
Amikishiyev S.
Aypak A.
Bes C.
Bolukçu S.
İçten S.
Topeli A.
Bektaş M.
Yiğit Arslan B.
Öztürk S.
Çomoğlu Ş.
Aydın S.
Küçükşahin O.
İçaçan O. C.
İnce B.
Aghamuradov S.
Yalçın Mutlu M.
Şimşek F.
Emre S.
Üstün C.
Ergen P.
Aydın Ö.
Meriç Koç M.
Sevindik Ö. G.
Odabaşı Z.
Korten V.
Bodur H.
Güner R.
Ünal S.
Koçak M.
Gül A.
Daha Fazlası
Survival outcomes of hypomethylating agents maintenance therapy in new diagnosed AML patients: Real experience data
Rituximab-Vemurafenib Combination for the Treatment of Relapsed/ Refractory Hairy Cell Leukemia
Clinical Lymphoma Myeloma & Leukemia, 2022 (SCI-Expanded)
Clinical Characteristics and Outcomes of COVID-19 in Turkish Patients with Hematological Malignancies COVID-19 Geçiren Türk Hematolojik Malignite Hastalarının Klinik Özellikleri ve Sonuçları
Civriz Bozdağ S.
Seval G. C.
Yönal Hindilerden İ.
Hindilerden F.
Andıç N.
Baydar M.
Aydın Kaynar L.
Toprak S. K.
Göksoy H. S.
Balık Aydın B.
Demirci U.
Can F.
Özkocaman V.
Gündüz E.
Güven Z. T.
Özkurt Z. N.
Demircioğlu S.
Beksaç M.
İnce İ.
Yılmaz U.
Küçükdiler H. E.
Abishov E.
Yavuz B.
Ataş Ü.
Mutlu Y. G.
Baş V.
Özkalemkaş F.
Teke H. Ü.
Gürsoy V.
Çelik S.
Çiftçiler R.
Yağcı M.
Topçuoğlu P.
Çeneli Ö.
Abbasov H.
Selim C.
Ar M. C.
Yücel O. K.
Sadri S.
Albayrak C.
Demir A. M.
Güler N.
Keklik M.
Terzi H.
Doğan A.
Yegin Z. A.
Yüksel M. K.
Sadri S.
Yavaşoğlu İ.
Beköz H. S.
Aksu T.
Maral S.
Erol V.
Kaynar L.
İlhan O.
Bolaman A. Z.
Sevindik Ö. G.
Akyay A.
Özcan M.
Gürman G.
Ünal Ş.
Yavuz Y.
Küçükkaya R. D.
Özsan G. H.
Daha Fazlası
A Real-life Turkish Experience of Venetoclax Treatment in High-risk Myelodysplastic Syndrome and Acute Myeloid Leukemia
An interim analysis of the Turkish Myeloma Registry among patients who have received up to two lines of therapy
Persistent polyclonal b-cell lymphocytosis with binucleated lymphocytes Çift çekirdekli lenfositler ile karakterize, kalıcı poliklonal b-hücreli lenfositoz
The 46th Annual Meeting of the European Society for Blood and Marrow Transplantation: Physicians Poster Session (P001-P706)
What are the factors affecting survival after autologous stem cell transplantation in patients with multiple myeloma?
Ibrutinib As a Promising Treatment for Pulmonary Complications Due to Refractory Chronic Graft Versus Host Disease
A single center cohort of 40 severe COVID-19 patients who were treated with convalescent plasma
Correlation between serum vitamin D level and dichotomous distribution of hematological parameters in a cohort of 12709 patients
The Turkish experience with therapeutic plasma exchange: A national survey
Korkmaz S.
Solmaz Medeni S.
Demirkan F.
Kalayoglu Besisik S.
Altay Dadin S.
Akgün Çağlıyan G.
Kabukcu Hacioglu S.
Sarı İ.
Gören Şahin D.
Arat M.
Dağdaş S.
Özet G.
Kutlu N.
Karaağaç Akyol T.
Özcebe O. İ.
Üsküdar Teke H.
Kiper Unal D.
Güner N.
Tombak A.
Çelik H.
Bay İ.
Kiki İ.
Özgür G.
Erkurt M. A.
Özatlı D.
Meletli Ö.
Demircioğlu S.
Demir C.
Kurtoğlu E.
Vural F.
Töbü M.
Karakuş A.
Ayyildiz O.
Dal M. S.
Afacan Ozturk B.
Albayrak M.
Ocakçı S.
Bolaman Z.
Sönmez M.
Karakuş V.
Sevindik Ö. G.
Berber İ.
Doğu M. H.
Gültürk E.
Ulaş T.
Payzin B.
Kuku İ.
Çağırgan S.
Altuntaş F.
Daha Fazlası
Prognostic Factors in Elderly Patients with Diffuse Large B-Cell Lymphoma and Their Treatment Results
Polysomy 8 Syndrome: A Distinct Clinical Entity Comprising of Myelomonocytic/Monocytic Lineage Involvement in Acute Leukemia
Acute lymphoblastic leukemia in routine practice: A Turkish multicenter study Rutin uygulamada akut lenfoblastik lösemi: Türkiye’den çok merkezli bir çalışma
A Comparison of Fresenius Com.Tec Cell and Spectra Optia Cell Separators for Autologous and Allogeneic Stem Cell Collections: Single Center Experience
Can Neutrophil-to-Lymphocyte Ratio, Monocyte-to-Lymphocyte Ratio, and Platelet-to-Lymphocyte Ratio at Day +100 be used as a prognostic marker in Multiple Myeloma patients with autologous transplantation?
Nodular lymphocyte predominant Hodgkin's lymphoma in daily practice: A multicenter experience
Is the platelet-to-lymphocyte ratio a new prognostic marker in multiple myeloma?
Does reinfusion of stem cell products on multiple days affect engraftment? Çoklu gün kök hücre reinfüzyonu engrafmanı etkiler mi?
Current status of art mobilization in Myeloma
Predictive value of stathmin-1 and osteopontin expression for taxan resistance in metastatic castrate-resistant prostate cancer
Ex vivo evaluation of the effect of regulatory T cells on the anti-tumor activity of bortezomib in multiple myeloma
Nilotinib does not alter the secretory functions of carotid artery endothelial cells in a prothrombotic or antithrombotic fashion
Hypoalbuminemia is a surrogate biomarker of poor prognosis in myelodysplastic syndrome even when adjusting for comorbidities
IPSET-thrombosis better identifies thrombosis-free survival: A Turkish cohort
TREATMENT OUTCOMES OF RELAPSED/ REFRACTORY HODGKIN AND AGGRESIVE NON-HODGKIN LYMPHOMA PATIENTS
Renal and Neurological Response with Eculizumab in a Patient with Transplant Associated Thrombotic Microangiopathy after Allogeneic Hematopoietic Progenitor Cell Transplantation
Eltrombopag for the treatment of immune thrombocytopenia: The aegean region of Turkey experience İmmün Trombositopeni Tedavisinde Eltrombopag: Türkiye Ege Bölgesi Deneyimi
Hyperglycemia is associated with lower levels of urokinase-type plasminogen activator and urokinase-type plasminogen activator receptor in wound fluid
Is the BFM regimen feasible for the treatment of adult acute lymphoblastic Leukemia? A retrospective analysis of the outcomes of BFM and hyper-CVAD chemotherapy in two centers
13032 Disseminated Fusarium Infection in an Acute Lymphoblastic Leukemia (ALL) Patient after Allogeneic Bone Marrow Transplantation
Effect of pretransplant Bortezomib Induction in Multiple Myeloma Patients Single Center Experience
Özsan G. H.
Sevindik Ö. G.
Demirkan F.
Katgı A.
Solmaz Ş.
Özcan M. A.
Pişkin Ö.
Alacacıoğlu İ.
Ündar B.
Daha Fazlası
Clinical Lymphoma Myeloma Leukemia, Cilt: 13, Sayı: 1, 2013 (SCI-Expanded)
A case of Relapsed Multiple Myeloma with Central Nervous System Involvement Longer Survival with Novel Agents
Demirkan F.
Sevindik Ö. G.
Özsan G. H.
Katgı A.
Solmaz Ş.
Özcan M. A.
Pişkin Ö.
Alacacıoğlu İ.
Ündar B.
Daha Fazlası
Clinical Lymphoma Myeloma Leukemia, Cilt: 13, Sayı: 1, 2013 (SCI-Expanded)
Successful hematopoietic engraftment with gray platelets after allogeneic hematopoietic stem cell transplantation from gray platelet syndrome donor
Disseminated Fusarium Infection in an Acute Lymphoblastic Leukemia (ALL) Patient after Allogeneic Bone Marrow Transplantation
A rare cause of renovascular hypertension: Takayasu arteritis with only renal artery involvement
Diğer Dergilerde Yayınlanan Makaleler 11
Quality of Life Assessment with EORTC QLQ in Patients with Hodgkin Lymphoma: Multicenter Study
Quality of Life Assessment with EORTC QLQ in Patients with Multiple Myeloma: Multicenter Study
Otolog Kök Hücre Transplantasyonunda Sitomegalovirüs (CMV) ve Hepatit B (HBV) Reaktivasyonu: Tek Merkez Deneyimi
Evaluation of Neurological Imaging After Hematopoietic Stem Cell Transplantation In Adults
Retrospective Evaluation of Patients with and without Primary Antifungal Prophylaxis During Remission Induction Chemotherapy in Patients with Acute Myeloid Leukemia
A Case of Severe Plasmodium falciparum Malaria Co-Infected with HIV Improved with Exchange Transfusion
Kronik Myeloid Lösemi Tanılı Hastalarımızın Retrospektif Değerlendirilmesi.
Karaman A.
Solmaz Medeni Ş.
Sevindik Ö. G.
Acar C.
Kahraman S.
Tunalı S.
Alacacıoğlu İ.
Altıngöz O.
Pişkin Ö.
Demirkan F.
Özsan G. H.
Özcan M. A.
Daha Fazlası
Dokuz Eylül Üniversitesi Tıp Fakültesi Dergisi, Cilt: 30, Sayı: 3, 2017